These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11205158)

  • 1. The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity.
    Barzilai A; Zilkha-Falb R; Daily D; Stern N; Offen D; Ziv I; Melamed E; Shirvan A
    J Neural Transm Suppl; 2000; (60):59-76. PubMed ID: 11205158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of T-complex protein-1delta in dopamine triggered apoptosis in chick embryo sympathetic neurons.
    Zilkha-Falb R; Barzilai A; Djaldeti R; Ziv I; Melamed E; Shirvan A
    J Biol Chem; 2000 Nov; 275(46):36380-7. PubMed ID: 10954701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?
    Barzilai A; Melamed E; Shirvan A
    Cell Mol Neurobiol; 2001 Jun; 21(3):215-35. PubMed ID: 11569535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semaphorins as mediators of neuronal apoptosis.
    Shirvan A; Ziv I; Fleminger G; Shina R; He Z; Brudo I; Melamed E; Barzilai A
    J Neurochem; 1999 Sep; 73(3):961-71. PubMed ID: 10461885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nigrostriatal neuronal death in Parkinson's disease--a passive or an active genetically-controlled process?
    Ziv I; Barzilai A; Offen D; Nardi N; Melamed E
    J Neural Transm Suppl; 1997; 49():69-76. PubMed ID: 9266415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology.
    Simunovic F; Yi M; Wang Y; Macey L; Brown LT; Krichevsky AM; Andersen SL; Stephens RM; Benes FM; Sonntag KC
    Brain; 2009 Jul; 132(Pt 7):1795-809. PubMed ID: 19052140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of control mechanisms of dopamine-induced apoptosis--a future approach to the treatment of Parkinson's disease?
    Ziv I; Offen D; Barzilai A; Haviv R; Stein R; Zilkha-Falb R; Shirvan A; Melamed E
    J Neural Transm Suppl; 1997; 49():195-202. PubMed ID: 9266428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine-melanin induces apoptosis in PC12 cells; possible implications for the etiology of Parkinson's disease.
    Offen D; Ziv I; Barzilai A; Gorodin S; Glater E; Hochman A; Melamed E
    Neurochem Int; 1997 Aug; 31(2):207-16. PubMed ID: 9220453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress regulated genes in nigral dopaminergic neuronal cells: correlation with the known pathology in Parkinson's disease.
    Yoo MS; Chun HS; Son JJ; DeGiorgio LA; Kim DJ; Peng C; Son JH
    Brain Res Mol Brain Res; 2003 Jan; 110(1):76-84. PubMed ID: 12573535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin protects human dopaminergic neuroblastoma cells against dopamine-induced apoptosis.
    Jiang H; Ren Y; Zhao J; Feng J
    Hum Mol Genet; 2004 Aug; 13(16):1745-54. PubMed ID: 15198987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine.
    Junn E; Mouradian MM
    Neurosci Lett; 2002 Mar; 320(3):146-50. PubMed ID: 11852183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of mitosis-related genes during dopamine-triggered apoptosis in sympathetic neurons.
    Shirvan A; Ziv I; Barzilai A; Djaldeti R; Zilkh-Falb R; Michlin T; Melamed E
    J Neural Transm Suppl; 1997; 50():67-78. PubMed ID: 9120426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of gender on nigral gene expression and parkinson disease.
    Cantuti-Castelvetri I; Keller-McGandy C; Bouzou B; Asteris G; Clark TW; Frosch MP; Standaert DG
    Neurobiol Dis; 2007 Jun; 26(3):606-14. PubMed ID: 17412603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of proteasomal inhibition and apoptosis induced in N27 mesencephalic cells by dopamine and MG132.
    Zafar KS; Inayat-Hussain SH; Ross D
    J Neurochem; 2007 Aug; 102(3):913-21. PubMed ID: 17504267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic neuron-specific deletion of p53 gene is neuroprotective in an experimental Parkinson's disease model.
    Qi X; Davis B; Chiang YH; Filichia E; Barnett A; Greig NH; Hoffer B; Luo Y
    J Neurochem; 2016 Sep; 138(5):746-57. PubMed ID: 27317935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.
    Wang YQ; Bian GL; Bai Y; Cao R; Chen LW
    Neurochem Int; 2008 Sep; 53(3-4):56-62. PubMed ID: 18639597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the leucine-rich repeat protein LINGO-1 enhances survival, structure, and function of dopaminergic neurons in Parkinson's disease models.
    Inoue H; Lin L; Lee X; Shao Z; Mendes S; Snodgrass-Belt P; Sweigard H; Engber T; Pepinsky B; Yang L; Beal MF; Mi S; Isacson O
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14430-5. PubMed ID: 17726113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine selectively sensitizes dopaminergic neurons to rotenone-induced apoptosis.
    Ahmadi FA; Grammatopoulos TN; Poczobutt AM; Jones SM; Snell LD; Das M; Zawada WM
    Neurochem Res; 2008 May; 33(5):886-901. PubMed ID: 17992568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of insulin-like-growth-factor-1 against dopamine-induced neurotoxicity in human and rodent neuronal cultures: possible implications for Parkinson's disease.
    Offen D; Shtaif B; Hadad D; Weizman A; Melamed E; Gil-Ad I
    Neurosci Lett; 2001 Dec; 316(3):129-32. PubMed ID: 11744219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.